

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 7.40403764 |
| 2 | glutamate secretion (GO:0014047) | 6.80494851 |
| 3 | fatty acid elongation (GO:0030497) | 6.62788661 |
| 4 | ensheathment of neurons (GO:0007272) | 6.51431292 |
| 5 | axon ensheathment (GO:0008366) | 6.51431292 |
| 6 | myelination (GO:0042552) | 6.48364565 |
| 7 | cellular potassium ion homeostasis (GO:0030007) | 6.01837331 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 6.00632064 |
| 9 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.92277741 |
| 10 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 5.84235608 |
| 11 | sodium ion export (GO:0071436) | 5.54980190 |
| 12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.51261893 |
| 13 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.47436767 |
| 14 | myelin maintenance (GO:0043217) | 5.36435962 |
| 15 | neurotransmitter secretion (GO:0007269) | 5.17316534 |
| 16 | regulation of synaptic vesicle transport (GO:1902803) | 5.13840622 |
| 17 | locomotory exploration behavior (GO:0035641) | 4.95177770 |
| 18 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.78807494 |
| 19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.68286086 |
| 20 | oligodendrocyte differentiation (GO:0048709) | 4.61551883 |
| 21 | positive regulation of synapse maturation (GO:0090129) | 4.60104930 |
| 22 | vocalization behavior (GO:0071625) | 4.54480041 |
| 23 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.51463767 |
| 24 | negative regulation of neurotransmitter transport (GO:0051589) | 4.42654881 |
| 25 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.40622049 |
| 26 | negative regulation of protein localization to cell surface (GO:2000009) | 4.38568106 |
| 27 | establishment of mitochondrion localization (GO:0051654) | 4.37609122 |
| 28 | creatine metabolic process (GO:0006600) | 4.30833317 |
| 29 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.30656412 |
| 30 | potassium ion homeostasis (GO:0055075) | 4.30625307 |
| 31 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.26884090 |
| 32 | potassium ion import (GO:0010107) | 4.26260794 |
| 33 | neurotransmitter transport (GO:0006836) | 4.22692157 |
| 34 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.22281577 |
| 35 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.14672948 |
| 36 | L-amino acid import (GO:0043092) | 4.14111472 |
| 37 | postsynaptic membrane organization (GO:0001941) | 4.13711247 |
| 38 | presynaptic membrane organization (GO:0097090) | 4.12474358 |
| 39 | exploration behavior (GO:0035640) | 4.08252672 |
| 40 | apical protein localization (GO:0045176) | 4.07824425 |
| 41 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.02386543 |
| 42 | regulation of collateral sprouting (GO:0048670) | 3.98468474 |
| 43 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.94671016 |
| 44 | synaptic transmission, glutamatergic (GO:0035249) | 3.91616236 |
| 45 | glycerophospholipid catabolic process (GO:0046475) | 3.90947517 |
| 46 | regulation of neurotransmitter levels (GO:0001505) | 3.89340258 |
| 47 | asymmetric protein localization (GO:0008105) | 3.85826065 |
| 48 | positive regulation of dendritic spine development (GO:0060999) | 3.85822100 |
| 49 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.84721449 |
| 50 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.83873240 |
| 51 | positive regulation of membrane potential (GO:0045838) | 3.80058632 |
| 52 | regulation of neurotransmitter secretion (GO:0046928) | 3.77268484 |
| 53 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.77013660 |
| 54 | photoreceptor cell differentiation (GO:0046530) | 3.76317888 |
| 55 | eye photoreceptor cell differentiation (GO:0001754) | 3.76317888 |
| 56 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.73719256 |
| 57 | regulation of synaptic plasticity (GO:0048167) | 3.72640929 |
| 58 | astrocyte development (GO:0014002) | 3.72025972 |
| 59 | regulation of synapse maturation (GO:0090128) | 3.70645713 |
| 60 | response to methylmercury (GO:0051597) | 3.69862838 |
| 61 | adult walking behavior (GO:0007628) | 3.68966049 |
| 62 | cellular sodium ion homeostasis (GO:0006883) | 3.67828880 |
| 63 | neuromuscular process controlling balance (GO:0050885) | 3.67565178 |
| 64 | cell communication by electrical coupling (GO:0010644) | 3.67120121 |
| 65 | protein localization to synapse (GO:0035418) | 3.66777196 |
| 66 | substantia nigra development (GO:0021762) | 3.62797335 |
| 67 | presynaptic membrane assembly (GO:0097105) | 3.61734179 |
| 68 | neuron-neuron synaptic transmission (GO:0007270) | 3.60861018 |
| 69 | cholesterol biosynthetic process (GO:0006695) | 3.60371667 |
| 70 | regulation of synapse structural plasticity (GO:0051823) | 3.60274817 |
| 71 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.58928358 |
| 72 | glutamate receptor signaling pathway (GO:0007215) | 3.58090411 |
| 73 | regulation of ARF protein signal transduction (GO:0032012) | 3.57351836 |
| 74 | import into cell (GO:0098657) | 3.57220329 |
| 75 | acidic amino acid transport (GO:0015800) | 3.56981970 |
| 76 | synaptic vesicle endocytosis (GO:0048488) | 3.52220503 |
| 77 | regulation of neurotransmitter transport (GO:0051588) | 3.48684206 |
| 78 | response to redox state (GO:0051775) | 3.48064609 |
| 79 | dendritic spine morphogenesis (GO:0060997) | 3.46983816 |
| 80 | membrane tubulation (GO:0097320) | 3.42964273 |
| 81 | regulation of postsynaptic membrane potential (GO:0060078) | 3.41758873 |
| 82 | long-term synaptic potentiation (GO:0060291) | 3.35571771 |
| 83 | long-term memory (GO:0007616) | 3.33586257 |
| 84 | neuronal action potential propagation (GO:0019227) | 3.33551691 |
| 85 | auditory behavior (GO:0031223) | 3.32962236 |
| 86 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.29780639 |
| 87 | regulation of vesicle fusion (GO:0031338) | 3.27371889 |
| 88 | myelination in peripheral nervous system (GO:0022011) | 3.26374596 |
| 89 | peripheral nervous system axon ensheathment (GO:0032292) | 3.26374596 |
| 90 | membrane depolarization during action potential (GO:0086010) | 3.26180000 |
| 91 | regulation of dendritic spine development (GO:0060998) | 3.25498625 |
| 92 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.25253012 |
| 93 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.22677704 |
| 94 | L-glutamate transport (GO:0015813) | 3.19172814 |
| 95 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.18965405 |
| 96 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.18505187 |
| 97 | sterol biosynthetic process (GO:0016126) | 3.16061514 |
| 98 | neuron cell-cell adhesion (GO:0007158) | 3.15778973 |
| 99 | membrane depolarization (GO:0051899) | 3.13834110 |
| 100 | positive regulation of neurotransmitter transport (GO:0051590) | 3.13256295 |
| 101 | proline transport (GO:0015824) | 3.12611253 |
| 102 | glycine transport (GO:0015816) | 3.12228581 |
| 103 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.12105887 |
| 104 | adhesion of symbiont to host cell (GO:0044650) | 3.11983639 |
| 105 | virion attachment to host cell (GO:0019062) | 3.11983639 |
| 106 | regulation of synaptic transmission (GO:0050804) | 3.11392111 |
| 107 | transmission of nerve impulse (GO:0019226) | 3.10604115 |
| 108 | cell differentiation in hindbrain (GO:0021533) | 3.09699062 |
| 109 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.09407459 |
| 110 | amino acid import (GO:0043090) | 3.08742271 |
| 111 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.07745936 |
| 112 | protein palmitoylation (GO:0018345) | 3.07723737 |
| 113 | neuromuscular process controlling posture (GO:0050884) | 3.05655929 |
| 114 | layer formation in cerebral cortex (GO:0021819) | 3.04394363 |
| 115 | amyloid precursor protein metabolic process (GO:0042982) | 3.02765967 |
| 116 | cerebellar granule cell differentiation (GO:0021707) | 3.01480530 |
| 117 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.00566354 |
| 118 | negative regulation of axonogenesis (GO:0050771) | 3.00289001 |
| 119 | neurotransmitter uptake (GO:0001504) | 2.99717338 |
| 120 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.98467694 |
| 121 | response to lipoprotein particle (GO:0055094) | 2.96491777 |
| 122 | positive regulation of dendrite development (GO:1900006) | 2.95043300 |
| 123 | negative regulation of JUN kinase activity (GO:0043508) | 2.94005847 |
| 124 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.93996002 |
| 125 | neuron remodeling (GO:0016322) | 2.92801040 |
| 126 | synaptic vesicle maturation (GO:0016188) | 2.88773786 |
| 127 | regulation of lipoprotein metabolic process (GO:0050746) | 2.86024562 |
| 128 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.84326709 |
| 129 | isoprenoid biosynthetic process (GO:0008299) | 2.84042328 |
| 130 | neuronal ion channel clustering (GO:0045161) | 2.79246407 |
| 131 | axon development (GO:0061564) | 2.78378261 |
| 132 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.74692089 |
| 133 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.74460882 |
| 134 | GPI anchor biosynthetic process (GO:0006506) | 2.72357447 |
| 135 | limb bud formation (GO:0060174) | 2.70962969 |
| 136 | cyclic nucleotide catabolic process (GO:0009214) | 2.69217007 |
| 137 | peptidyl-cysteine modification (GO:0018198) | 2.68578133 |
| 138 | GPI anchor metabolic process (GO:0006505) | 2.67771398 |
| 139 | glycosylceramide metabolic process (GO:0006677) | 2.67619910 |
| 140 | negative regulation of inclusion body assembly (GO:0090084) | 2.67332090 |
| 141 | very long-chain fatty acid metabolic process (GO:0000038) | 2.66577019 |
| 142 | nerve growth factor signaling pathway (GO:0038180) | 2.65126382 |
| 143 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.64900706 |
| 144 | magnesium ion transport (GO:0015693) | 2.62980989 |
| 145 | cellular response to epinephrine stimulus (GO:0071872) | 2.61914335 |
| 146 | positive regulation of action potential (GO:0045760) | 2.61663598 |
| 147 | enteric nervous system development (GO:0048484) | 2.61645453 |
| 148 | glial cell development (GO:0021782) | 2.60771734 |
| 149 | response to lead ion (GO:0010288) | 2.60500445 |
| 150 | positive regulation of glial cell differentiation (GO:0045687) | 2.57982696 |
| 151 | regulation of catecholamine metabolic process (GO:0042069) | 2.55033463 |
| 152 | regulation of dopamine metabolic process (GO:0042053) | 2.55033463 |
| 153 | peripheral nervous system development (GO:0007422) | 2.54918962 |
| 154 | adult locomotory behavior (GO:0008344) | 2.54468180 |
| 155 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.52978056 |
| 156 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.52978056 |
| 157 | negative regulation of macroautophagy (GO:0016242) | 2.52644972 |
| 158 | gamma-aminobutyric acid transport (GO:0015812) | 2.52300669 |
| 159 | iron coordination entity transport (GO:1901678) | 2.51950330 |
| 160 | Golgi to endosome transport (GO:0006895) | 2.51572508 |
| 161 | regulation of interleukin-13 production (GO:0032656) | 2.49697531 |
| 162 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.48440981 |
| 163 | positive regulation of gliogenesis (GO:0014015) | 2.47771322 |
| 164 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.47280321 |
| 165 | neural nucleus development (GO:0048857) | 2.46285098 |
| 166 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.46277627 |
| 167 | protein localization to endosome (GO:0036010) | 2.43876640 |
| 168 | negative regulation of acute inflammatory response (GO:0002674) | 2.43389402 |
| 169 | negative regulation of axon extension (GO:0030517) | 2.42798573 |
| 170 | synaptic vesicle exocytosis (GO:0016079) | 2.42531215 |
| 171 | cellular response to catecholamine stimulus (GO:0071870) | 2.41161487 |
| 172 | central nervous system myelination (GO:0022010) | 11.4792234 |
| 173 | axon ensheathment in central nervous system (GO:0032291) | 11.4792234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.25618764 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.00602763 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.65567000 |
| 4 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.62171791 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.61189299 |
| 6 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.43526154 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.36469896 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.27366309 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.27366309 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.26546525 |
| 11 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.26062520 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.21026603 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.19477984 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.15837427 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.13568575 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.06780804 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.03486979 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.02798863 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.02404867 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02311947 |
| 21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.98408711 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.98348648 |
| 23 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.92479069 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.92262257 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87476945 |
| 26 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.86375635 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.80405541 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71473353 |
| 29 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.70749375 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.68716283 |
| 31 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.68712152 |
| 32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.62030207 |
| 33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.56354675 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49821000 |
| 35 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.49251065 |
| 36 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.49206186 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 1.47224017 |
| 38 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.46024962 |
| 39 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.45121274 |
| 40 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.44801743 |
| 41 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.39971408 |
| 42 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.38482508 |
| 43 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.36989016 |
| 44 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.36040238 |
| 45 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.34157390 |
| 46 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.34029568 |
| 47 | VDR_22108803_ChIP-Seq_LS180_Human | 1.33481609 |
| 48 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.32060145 |
| 49 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.29271971 |
| 50 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28211303 |
| 51 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.26478528 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.26365724 |
| 53 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25708524 |
| 54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24480175 |
| 55 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.24385463 |
| 56 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22981973 |
| 57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.21144544 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19354702 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.18485538 |
| 60 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18407694 |
| 61 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.18201098 |
| 62 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.18024413 |
| 63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.17682711 |
| 64 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.17118858 |
| 65 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16921890 |
| 66 | AR_19668381_ChIP-Seq_PC3_Human | 1.16734331 |
| 67 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.16326456 |
| 68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16035953 |
| 69 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.15194336 |
| 70 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.14995122 |
| 71 | P300_19829295_ChIP-Seq_ESCs_Human | 1.14653389 |
| 72 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14608449 |
| 73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11405697 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11405697 |
| 75 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.11213415 |
| 76 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09086587 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08885606 |
| 78 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08688645 |
| 79 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08625891 |
| 80 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.06605741 |
| 81 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05034814 |
| 82 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04525036 |
| 83 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.04319683 |
| 84 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03753812 |
| 85 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.03569254 |
| 86 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03031542 |
| 87 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01484807 |
| 88 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00974481 |
| 89 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.97981544 |
| 90 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97595021 |
| 91 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97582609 |
| 92 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.97112742 |
| 93 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96757032 |
| 94 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96692314 |
| 95 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96506483 |
| 96 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.96480383 |
| 97 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96144986 |
| 98 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95116202 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94639266 |
| 100 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94273604 |
| 101 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94002031 |
| 102 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92702509 |
| 103 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92265432 |
| 104 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92134750 |
| 105 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91849986 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91716580 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.91499092 |
| 108 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90740320 |
| 109 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90651837 |
| 110 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90303655 |
| 111 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89687040 |
| 112 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.89603105 |
| 113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89458789 |
| 114 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89302858 |
| 115 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89259313 |
| 116 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89185399 |
| 117 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88966232 |
| 118 | FUS_26573619_Chip-Seq_HEK293_Human | 0.88724451 |
| 119 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88638828 |
| 120 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88097894 |
| 121 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87422133 |
| 122 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.86757134 |
| 123 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86076678 |
| 124 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.85904311 |
| 125 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.85166451 |
| 126 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84818960 |
| 127 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.84774170 |
| 128 | TBL1_22424771_ChIP-Seq_293T_Human | 0.84722748 |
| 129 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.84441311 |
| 130 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.83761380 |
| 131 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.83745194 |
| 132 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.82934414 |
| 133 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.82572410 |
| 134 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.76693100 |
| 135 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.75679806 |
| 136 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.75306650 |
| 137 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75084783 |
| 138 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.75084783 |
| 139 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.74551505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.18860572 |
| 2 | MP0003880_abnormal_central_pattern | 4.17540078 |
| 3 | MP0004270_analgesia | 3.46610757 |
| 4 | MP0003950_abnormal_plasma_membrane | 3.36230344 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.02655766 |
| 6 | MP0003690_abnormal_glial_cell | 2.91179123 |
| 7 | MP0002272_abnormal_nervous_system | 2.84745804 |
| 8 | MP0004885_abnormal_endolymph | 2.72947261 |
| 9 | MP0003329_amyloid_beta_deposits | 2.67113785 |
| 10 | MP0005171_absent_coat_pigmentation | 2.66854950 |
| 11 | MP0001486_abnormal_startle_reflex | 2.65631987 |
| 12 | MP0001529_abnormal_vocalization | 2.58342034 |
| 13 | MP0002064_seizures | 2.57663562 |
| 14 | MP0004142_abnormal_muscle_tone | 2.42367157 |
| 15 | MP0004742_abnormal_vestibular_system | 2.36558818 |
| 16 | MP0009046_muscle_twitch | 2.36324512 |
| 17 | MP0003635_abnormal_synaptic_transmissio | 2.31734423 |
| 18 | MP0003634_abnormal_glial_cell | 2.28834064 |
| 19 | MP0001905_abnormal_dopamine_level | 2.26272881 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.24318701 |
| 21 | MP0009745_abnormal_behavioral_response | 2.17757748 |
| 22 | MP0003879_abnormal_hair_cell | 2.16204917 |
| 23 | MP0003136_yellow_coat_color | 2.04609786 |
| 24 | MP0000778_abnormal_nervous_system | 2.01540711 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 1.98270682 |
| 26 | MP0004043_abnormal_pH_regulation | 1.90811243 |
| 27 | MP0001485_abnormal_pinna_reflex | 1.89210219 |
| 28 | MP0002229_neurodegeneration | 1.88803053 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.87003708 |
| 30 | MP0005410_abnormal_fertilization | 1.84268333 |
| 31 | MP0008569_lethality_at_weaning | 1.79533235 |
| 32 | MP0003632_abnormal_nervous_system | 1.74873346 |
| 33 | MP0003787_abnormal_imprinting | 1.66856502 |
| 34 | MP0002063_abnormal_learning/memory/cond | 1.65916138 |
| 35 | MP0002572_abnormal_emotion/affect_behav | 1.64802398 |
| 36 | MP0005409_darkened_coat_color | 1.64475827 |
| 37 | MP0000955_abnormal_spinal_cord | 1.58268273 |
| 38 | MP0001984_abnormal_olfaction | 1.51281718 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.51148789 |
| 40 | MP0003631_nervous_system_phenotype | 1.50350625 |
| 41 | MP0001970_abnormal_pain_threshold | 1.45309664 |
| 42 | MP0002067_abnormal_sensory_capabilities | 1.45004669 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.44973262 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.42451466 |
| 45 | MP0003633_abnormal_nervous_system | 1.40536297 |
| 46 | MP0006276_abnormal_autonomic_nervous | 1.39180981 |
| 47 | MP0002066_abnormal_motor_capabilities/c | 1.38009840 |
| 48 | MP0004381_abnormal_hair_follicle | 1.36800142 |
| 49 | MP0004147_increased_porphyrin_level | 1.36514948 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.33627393 |
| 51 | MP0004924_abnormal_behavior | 1.33627393 |
| 52 | MP0005167_abnormal_blood-brain_barrier | 1.32574507 |
| 53 | MP0000604_amyloidosis | 1.30793315 |
| 54 | MP0008260_abnormal_autophagy | 1.29161335 |
| 55 | MP0010678_abnormal_skin_adnexa | 1.28081562 |
| 56 | MP0000462_abnormal_digestive_system | 1.25321637 |
| 57 | MP0000747_muscle_weakness | 1.24735750 |
| 58 | MP0002822_catalepsy | 1.23742182 |
| 59 | MP0005623_abnormal_meninges_morphology | 1.23359395 |
| 60 | MP0001968_abnormal_touch/_nociception | 1.22591968 |
| 61 | MP0005451_abnormal_body_composition | 1.22145583 |
| 62 | MP0004145_abnormal_muscle_electrophysio | 1.20366853 |
| 63 | MP0002733_abnormal_thermal_nociception | 1.20200697 |
| 64 | MP0001963_abnormal_hearing_physiology | 1.15496603 |
| 65 | MP0000383_abnormal_hair_follicle | 1.12960350 |
| 66 | MP0002752_abnormal_somatic_nervous | 1.10188232 |
| 67 | MP0001299_abnormal_eye_distance/ | 1.08526427 |
| 68 | MP0003806_abnormal_nucleotide_metabolis | 1.08475982 |
| 69 | MP0003123_paternal_imprinting | 1.07866421 |
| 70 | MP0003122_maternal_imprinting | 1.07618616 |
| 71 | MP0001346_abnormal_lacrimal_gland | 1.04786995 |
| 72 | MP0004134_abnormal_chest_morphology | 1.04493622 |
| 73 | MP0001501_abnormal_sleep_pattern | 1.01650692 |
| 74 | MP0008874_decreased_physiological_sensi | 1.01285942 |
| 75 | MP0003075_altered_response_to | 1.00184852 |
| 76 | MP0001502_abnormal_circadian_rhythm | 0.98744299 |
| 77 | MP0002736_abnormal_nociception_after | 0.97936051 |
| 78 | MP0001177_atelectasis | 0.97325450 |
| 79 | MP0002735_abnormal_chemical_nociception | 0.95541280 |
| 80 | MP0002184_abnormal_innervation | 0.91356584 |
| 81 | MP0002152_abnormal_brain_morphology | 0.88052752 |
| 82 | MP0005195_abnormal_posterior_eye | 0.87340440 |
| 83 | MP0000566_synostosis | 0.85532361 |
| 84 | MP0002638_abnormal_pupillary_reflex | 0.84227643 |
| 85 | MP0002557_abnormal_social/conspecific_i | 0.82404356 |
| 86 | MP0005058_abnormal_lysosome_morphology | 0.81644464 |
| 87 | MP0004811_abnormal_neuron_physiology | 0.81355781 |
| 88 | MP0001986_abnormal_taste_sensitivity | 0.79206598 |
| 89 | MP0001851_eye_inflammation | 0.78779141 |
| 90 | MP0005535_abnormal_body_temperature | 0.78770677 |
| 91 | MP0001661_extended_life_span | 0.74913370 |
| 92 | MP0003137_abnormal_impulse_conducting | 0.73886041 |
| 93 | MP0003195_calcinosis | 0.73864389 |
| 94 | MP0004036_abnormal_muscle_relaxation | 0.72909337 |
| 95 | MP0004130_abnormal_muscle_cell | 0.72114067 |
| 96 | MP0000647_abnormal_sebaceous_gland | 0.71504140 |
| 97 | MP0000749_muscle_degeneration | 0.71138631 |
| 98 | MP0001348_abnormal_lacrimal_gland | 0.71036313 |
| 99 | MP0005253_abnormal_eye_physiology | 0.70806872 |
| 100 | MP0002090_abnormal_vision | 0.69628642 |
| 101 | MP0005646_abnormal_pituitary_gland | 0.69018414 |
| 102 | MP0002069_abnormal_eating/drinking_beha | 0.67771731 |
| 103 | MP0006072_abnormal_retinal_apoptosis | 0.67371891 |
| 104 | MP0000579_abnormal_nail_morphology | 0.67196461 |
| 105 | MP0000026_abnormal_inner_ear | 0.67031956 |
| 106 | MP0003938_abnormal_ear_development | 0.66372878 |
| 107 | MP0005645_abnormal_hypothalamus_physiol | 0.65188504 |
| 108 | MP0008872_abnormal_physiological_respon | 0.65074096 |
| 109 | MP0009840_abnormal_foam_cell | 0.64472875 |
| 110 | MP0000003_abnormal_adipose_tissue | 0.63691834 |
| 111 | MP0002909_abnormal_adrenal_gland | 0.63595715 |
| 112 | MP0002295_abnormal_pulmonary_circulatio | 0.62756990 |
| 113 | MP0000762_abnormal_tongue_morphology | 0.61046650 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.60396209 |
| 115 | MP0004085_abnormal_heartbeat | 0.59533180 |
| 116 | MP0003045_fibrosis | 0.58622042 |
| 117 | MP0000639_abnormal_adrenal_gland | 0.58047431 |
| 118 | MP0000751_myopathy | 0.56510753 |
| 119 | MP0002133_abnormal_respiratory_system | 0.55708934 |
| 120 | MP0004215_abnormal_myocardial_fiber | 0.55154972 |
| 121 | MP0004510_myositis | 0.54696883 |
| 122 | MP0010769_abnormal_survival | 0.52953177 |
| 123 | MP0008877_abnormal_DNA_methylation | 0.51190730 |
| 124 | MP0000569_abnormal_digit_pigmentation | 0.50437970 |
| 125 | MP0010768_mortality/aging | 0.49267044 |
| 126 | MP0002082_postnatal_lethality | 0.48031531 |
| 127 | MP0010770_preweaning_lethality | 0.48031531 |
| 128 | MP0001943_abnormal_respiration | 0.46357778 |
| 129 | MP0005166_decreased_susceptibility_to | 0.45904331 |
| 130 | MP0003956_abnormal_body_size | 0.45308896 |
| 131 | MP0002089_abnormal_postnatal_growth/wei | 0.43636433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 6.12079262 |
| 2 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.08544463 |
| 3 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.08544463 |
| 4 | Febrile seizures (HP:0002373) | 5.25694637 |
| 5 | Abnormality of binocular vision (HP:0011514) | 4.86529936 |
| 6 | Diplopia (HP:0000651) | 4.86529936 |
| 7 | Peripheral hypomyelination (HP:0007182) | 4.74665311 |
| 8 | Abnormality of the corticospinal tract (HP:0002492) | 4.70646969 |
| 9 | Cerebral hypomyelination (HP:0006808) | 4.63556093 |
| 10 | Cerebral inclusion bodies (HP:0100314) | 4.37116547 |
| 11 | Sensory axonal neuropathy (HP:0003390) | 4.32819578 |
| 12 | Myokymia (HP:0002411) | 4.09971794 |
| 13 | Onion bulb formation (HP:0003383) | 4.08043603 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 4.06866737 |
| 15 | Parakeratosis (HP:0001036) | 3.96605412 |
| 16 | Abnormal auditory evoked potentials (HP:0006958) | 3.86065779 |
| 17 | Abnormal eating behavior (HP:0100738) | 3.78851346 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 3.71978002 |
| 19 | Spastic gait (HP:0002064) | 3.70684267 |
| 20 | Generalized tonic-clonic seizures (HP:0002069) | 3.70611637 |
| 21 | Visual hallucinations (HP:0002367) | 3.70119730 |
| 22 | Intention tremor (HP:0002080) | 3.59103437 |
| 23 | Dysmetria (HP:0001310) | 3.57405634 |
| 24 | Postural instability (HP:0002172) | 3.49264057 |
| 25 | Alacrima (HP:0000522) | 3.45576582 |
| 26 | Absence seizures (HP:0002121) | 3.36461688 |
| 27 | Ankle clonus (HP:0011448) | 3.35390821 |
| 28 | Hemiplegia (HP:0002301) | 3.33450924 |
| 29 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.31195110 |
| 30 | Scanning speech (HP:0002168) | 3.30274979 |
| 31 | Dialeptic seizures (HP:0011146) | 3.26775788 |
| 32 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.26509919 |
| 33 | Torticollis (HP:0000473) | 3.26030567 |
| 34 | Obstructive sleep apnea (HP:0002870) | 3.18913047 |
| 35 | Annular pancreas (HP:0001734) | 3.17085029 |
| 36 | Mutism (HP:0002300) | 3.16438863 |
| 37 | Papilledema (HP:0001085) | 3.14575743 |
| 38 | Truncal ataxia (HP:0002078) | 3.14493807 |
| 39 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.12544945 |
| 40 | Tetraplegia (HP:0002445) | 3.08015418 |
| 41 | Leukodystrophy (HP:0002415) | 3.06897931 |
| 42 | Termporal pattern (HP:0011008) | 2.97907796 |
| 43 | Insidious onset (HP:0003587) | 2.97907796 |
| 44 | CNS hypomyelination (HP:0003429) | 2.96128109 |
| 45 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.91629335 |
| 46 | Slow saccadic eye movements (HP:0000514) | 2.83671491 |
| 47 | Hemiparesis (HP:0001269) | 2.78083959 |
| 48 | Focal motor seizures (HP:0011153) | 2.77477530 |
| 49 | Delusions (HP:0000746) | 2.75604310 |
| 50 | Thickened helices (HP:0000391) | 2.73438449 |
| 51 | Focal dystonia (HP:0004373) | 2.71735508 |
| 52 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.70332908 |
| 53 | Depression (HP:0000716) | 2.69883406 |
| 54 | Decreased lacrimation (HP:0000633) | 2.69007965 |
| 55 | Retinal dysplasia (HP:0007973) | 2.67254308 |
| 56 | Status epilepticus (HP:0002133) | 2.66312258 |
| 57 | Anxiety (HP:0000739) | 2.60258935 |
| 58 | Clumsiness (HP:0002312) | 2.59498797 |
| 59 | Poor eye contact (HP:0000817) | 2.56630511 |
| 60 | Spastic paraparesis (HP:0002313) | 2.55425762 |
| 61 | Sleep apnea (HP:0010535) | 2.55077267 |
| 62 | Bradykinesia (HP:0002067) | 2.54817267 |
| 63 | Pheochromocytoma (HP:0002666) | 2.54252023 |
| 64 | Craniofacial dystonia (HP:0012179) | 2.52713378 |
| 65 | Action tremor (HP:0002345) | 2.52492675 |
| 66 | Bundle branch block (HP:0011710) | 2.51436744 |
| 67 | Cerebral hemorrhage (HP:0001342) | 2.49688913 |
| 68 | Split foot (HP:0001839) | 2.49230921 |
| 69 | Rigidity (HP:0002063) | 2.46980791 |
| 70 | Spastic tetraparesis (HP:0001285) | 2.43588073 |
| 71 | Absent septum pellucidum (HP:0001331) | 2.41898172 |
| 72 | Anteriorly placed anus (HP:0001545) | 2.41651100 |
| 73 | Epileptiform EEG discharges (HP:0011182) | 2.40345168 |
| 74 | Morphological abnormality of the inner ear (HP:0011390) | 2.40201896 |
| 75 | Megalencephaly (HP:0001355) | 2.40033838 |
| 76 | Muscle fiber splitting (HP:0003555) | 2.39260750 |
| 77 | Abnormality of the lower motor neuron (HP:0002366) | 2.37662981 |
| 78 | Foot dorsiflexor weakness (HP:0009027) | 2.37387817 |
| 79 | Abnormality of glycolysis (HP:0004366) | 2.34131167 |
| 80 | Increased serum pyruvate (HP:0003542) | 2.34131167 |
| 81 | Lower limb muscle weakness (HP:0007340) | 2.33788534 |
| 82 | Apathy (HP:0000741) | 2.33242871 |
| 83 | Akinesia (HP:0002304) | 2.32298603 |
| 84 | Hypoplastic pelvis (HP:0008839) | 2.30995785 |
| 85 | Aplasia involving bones of the extremities (HP:0009825) | 2.29880283 |
| 86 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.29880283 |
| 87 | Aplasia of the phalanges of the hand (HP:0009802) | 2.29880283 |
| 88 | Increased circulating renin level (HP:0000848) | 2.29874467 |
| 89 | Premature skin wrinkling (HP:0100678) | 2.29789967 |
| 90 | Metabolic alkalosis (HP:0200114) | 2.29605580 |
| 91 | Rapidly progressive (HP:0003678) | 2.29471228 |
| 92 | Poor speech (HP:0002465) | 2.29324714 |
| 93 | Impaired smooth pursuit (HP:0007772) | 2.29280677 |
| 94 | Insomnia (HP:0100785) | 2.29051483 |
| 95 | Stridor (HP:0010307) | 2.23033913 |
| 96 | White forelock (HP:0002211) | 2.21997322 |
| 97 | Choreoathetosis (HP:0001266) | 2.19694852 |
| 98 | Neuroendocrine neoplasm (HP:0100634) | 2.18754872 |
| 99 | Axonal loss (HP:0003447) | 2.18718833 |
| 100 | Abnormal social behavior (HP:0012433) | 2.16830281 |
| 101 | Impaired social interactions (HP:0000735) | 2.16830281 |
| 102 | Polyphagia (HP:0002591) | 2.16569644 |
| 103 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.15263891 |
| 104 | Abnormality of the foot musculature (HP:0001436) | 2.14883014 |
| 105 | Impaired vibratory sensation (HP:0002495) | 2.14236042 |
| 106 | Abnormality of the periventricular white matter (HP:0002518) | 2.12103966 |
| 107 | Limb dystonia (HP:0002451) | 2.11465485 |
| 108 | Patchy hypopigmentation of hair (HP:0011365) | 2.11025922 |
| 109 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.10911931 |
| 110 | Autoamputation (HP:0001218) | 2.09524011 |
| 111 | Epileptic encephalopathy (HP:0200134) | 2.09417624 |
| 112 | EEG with generalized epileptiform discharges (HP:0011198) | 2.09143792 |
| 113 | Clonus (HP:0002169) | 2.08107281 |
| 114 | Decreased motor nerve conduction velocity (HP:0003431) | 2.05550842 |
| 115 | Hypokalemic alkalosis (HP:0001949) | 2.05498051 |
| 116 | Paraparesis (HP:0002385) | 2.05187645 |
| 117 | Diminished motivation (HP:0000745) | 2.04846466 |
| 118 | Hypoplasia of the iris (HP:0007676) | 2.04760647 |
| 119 | Atonic seizures (HP:0010819) | 2.03100907 |
| 120 | Focal seizures (HP:0007359) | 2.02707819 |
| 121 | Stereotypic behavior (HP:0000733) | 2.02690566 |
| 122 | Dysdiadochokinesis (HP:0002075) | 2.02403697 |
| 123 | Methylmalonic acidemia (HP:0002912) | 2.02247180 |
| 124 | Heart block (HP:0012722) | 2.02100320 |
| 125 | Abnormality of the septum pellucidum (HP:0007375) | 2.00331329 |
| 126 | Ventricular fibrillation (HP:0001663) | 2.00015388 |
| 127 | Coronal craniosynostosis (HP:0004440) | 1.99900669 |
| 128 | Urinary urgency (HP:0000012) | 1.99671116 |
| 129 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.99086685 |
| 130 | Hypomagnesemia (HP:0002917) | 1.96843970 |
| 131 | Amblyopia (HP:0000646) | 1.93954008 |
| 132 | Hypsarrhythmia (HP:0002521) | 1.93888389 |
| 133 | Fetal akinesia sequence (HP:0001989) | 1.92292550 |
| 134 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.90912055 |
| 135 | Gowers sign (HP:0003391) | 1.90224147 |
| 136 | Hyporeflexia of lower limbs (HP:0002600) | 1.89914712 |
| 137 | Synostosis involving the elbow (HP:0003938) | 1.88619824 |
| 138 | Humeroradial synostosis (HP:0003041) | 1.88619824 |
| 139 | Broad-based gait (HP:0002136) | 1.88246907 |
| 140 | Urinary incontinence (HP:0000020) | 1.88148953 |
| 141 | Abnormality of saccadic eye movements (HP:0000570) | 1.87561376 |
| 142 | Slow progression (HP:0003677) | 1.87300704 |
| 143 | Distal sensory impairment (HP:0002936) | 1.87086464 |
| 144 | Gaze-evoked nystagmus (HP:0000640) | 1.87014515 |
| 145 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.86435454 |
| 146 | Incomplete penetrance (HP:0003829) | 1.84770122 |
| 147 | Bowel incontinence (HP:0002607) | 1.84604353 |
| 148 | Memory impairment (HP:0002354) | 1.83882473 |
| 149 | Hepatosplenomegaly (HP:0001433) | 1.83617363 |
| 150 | Infantile muscular hypotonia (HP:0008947) | 1.83381169 |
| 151 | Neuronal loss in central nervous system (HP:0002529) | 1.83200167 |
| 152 | Lower limb amyotrophy (HP:0007210) | 1.83165348 |
| 153 | Abnormal atrioventricular conduction (HP:0005150) | 1.83122321 |
| 154 | Spastic paraplegia (HP:0001258) | 1.82532137 |
| 155 | Hammertoe (HP:0001765) | 1.80533119 |
| 156 | Generalized myoclonic seizures (HP:0002123) | 1.75000769 |
| 157 | Peripheral demyelination (HP:0011096) | 1.74173410 |
| 158 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.74126408 |
| 159 | Abnormal large intestine physiology (HP:0012700) | 1.70152277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.74078701 |
| 2 | OXSR1 | 4.34656920 |
| 3 | PKN1 | 2.84532732 |
| 4 | EPHB1 | 2.83368630 |
| 5 | CDK19 | 2.67869255 |
| 6 | BCR | 2.63014340 |
| 7 | MAPKAPK5 | 2.38413493 |
| 8 | WNK4 | 2.32678745 |
| 9 | CAMKK1 | 2.26029184 |
| 10 | PRPF4B | 2.23147718 |
| 11 | FGFR2 | 2.21381119 |
| 12 | WNK1 | 2.14320675 |
| 13 | LIMK1 | 2.04295459 |
| 14 | MET | 2.00648861 |
| 15 | RIPK1 | 1.95637251 |
| 16 | PBK | 1.93603042 |
| 17 | UHMK1 | 1.92272064 |
| 18 | CAMK2B | 1.79220882 |
| 19 | NEK6 | 1.78455372 |
| 20 | CSNK1G3 | 1.76909727 |
| 21 | CSNK1A1L | 1.72837656 |
| 22 | PLK2 | 1.72354842 |
| 23 | NTRK1 | 1.62685415 |
| 24 | PNCK | 1.60223321 |
| 25 | TNIK | 1.59379515 |
| 26 | ROCK2 | 1.57084801 |
| 27 | PAK6 | 1.54491076 |
| 28 | EPHA4 | 1.54382768 |
| 29 | SGK494 | 1.50589273 |
| 30 | SGK223 | 1.50589273 |
| 31 | TESK2 | 1.50072472 |
| 32 | RIPK4 | 1.46550901 |
| 33 | CAMK2D | 1.45332864 |
| 34 | CSNK1G2 | 1.39917171 |
| 35 | CAMK1 | 1.38620424 |
| 36 | CSNK1G1 | 1.33669466 |
| 37 | CASK | 1.30946544 |
| 38 | CAMK2G | 1.25671520 |
| 39 | MARK1 | 1.19730037 |
| 40 | ICK | 1.19578780 |
| 41 | TYRO3 | 1.15144351 |
| 42 | FGR | 1.14413151 |
| 43 | SGK2 | 1.13982190 |
| 44 | DAPK1 | 1.13254941 |
| 45 | LATS2 | 1.11083489 |
| 46 | CLK1 | 1.08488858 |
| 47 | CAMKK2 | 1.06663673 |
| 48 | SIK2 | 1.01446237 |
| 49 | CDK5 | 1.00752196 |
| 50 | MST4 | 0.99722852 |
| 51 | PHKG1 | 0.99491877 |
| 52 | PHKG2 | 0.99491877 |
| 53 | CAMK2A | 0.95123348 |
| 54 | SGK3 | 0.95003463 |
| 55 | CDK14 | 0.94018617 |
| 56 | MAPK12 | 0.93544926 |
| 57 | STK38 | 0.92369417 |
| 58 | ALK | 0.91996476 |
| 59 | MARK2 | 0.91305048 |
| 60 | ARAF | 0.91196071 |
| 61 | CDK15 | 0.86777872 |
| 62 | MAP3K13 | 0.84327496 |
| 63 | KSR2 | 0.82662736 |
| 64 | PRKD1 | 0.81986540 |
| 65 | DYRK2 | 0.81445539 |
| 66 | CDK18 | 0.81264966 |
| 67 | PAK3 | 0.79769102 |
| 68 | MUSK | 0.77479041 |
| 69 | CDK11A | 0.77381231 |
| 70 | NTRK2 | 0.76453868 |
| 71 | PRKCQ | 0.75212457 |
| 72 | PDPK1 | 0.74910237 |
| 73 | PRKCH | 0.72812527 |
| 74 | TRPM7 | 0.72756337 |
| 75 | NTRK3 | 0.72003927 |
| 76 | MAP3K9 | 0.70608562 |
| 77 | PRKCE | 0.69946151 |
| 78 | PINK1 | 0.69743817 |
| 79 | PRKD3 | 0.69009089 |
| 80 | TNK2 | 0.67430293 |
| 81 | RPS6KA3 | 0.64655351 |
| 82 | CAMK4 | 0.63283341 |
| 83 | BMPR1B | 0.63153741 |
| 84 | MAP3K11 | 0.62781163 |
| 85 | BRSK1 | 0.60606755 |
| 86 | MAPK15 | 0.58968650 |
| 87 | FYN | 0.56053497 |
| 88 | LMTK2 | 0.53183340 |
| 89 | PRKG1 | 0.51826255 |
| 90 | DAPK3 | 0.50349165 |
| 91 | STK11 | 0.50329449 |
| 92 | PRKCZ | 0.49960795 |
| 93 | IRAK2 | 0.49441342 |
| 94 | MAPK13 | 0.46987985 |
| 95 | PRKACB | 0.46905992 |
| 96 | CSNK1A1 | 0.46841031 |
| 97 | KSR1 | 0.46804295 |
| 98 | MAP2K4 | 0.46798223 |
| 99 | CSNK1D | 0.45876156 |
| 100 | PDK1 | 0.44241697 |
| 101 | FES | 0.43221291 |
| 102 | ROCK1 | 0.43169359 |
| 103 | PTK2B | 0.43008377 |
| 104 | BRAF | 0.42189148 |
| 105 | DAPK2 | 0.42087259 |
| 106 | RET | 0.41421488 |
| 107 | MINK1 | 0.40043596 |
| 108 | CAMK1G | 0.39735001 |
| 109 | MAP3K2 | 0.39535167 |
| 110 | ERBB4 | 0.39381550 |
| 111 | ERBB2 | 0.38972651 |
| 112 | PRKCA | 0.38337154 |
| 113 | GSK3A | 0.38052849 |
| 114 | DMPK | 0.37542955 |
| 115 | RAF1 | 0.37201982 |
| 116 | TESK1 | 0.34161234 |
| 117 | PAK1 | 0.33579666 |
| 118 | MAP3K4 | 0.33573078 |
| 119 | MAP2K2 | 0.32878956 |
| 120 | BMX | 0.32722477 |
| 121 | PRKACA | 0.32544946 |
| 122 | DYRK1A | 0.32162891 |
| 123 | MAP3K1 | 0.31942223 |
| 124 | MAPK7 | 0.31750646 |
| 125 | RPS6KA5 | 0.31242563 |
| 126 | PRKCG | 0.30881376 |
| 127 | BMPR2 | 0.30600290 |
| 128 | PRKG2 | 0.30318548 |
| 129 | SRC | 0.29942926 |
| 130 | MAPK10 | 0.29781081 |
| 131 | MAP2K7 | 0.29546744 |
| 132 | JAK2 | 0.29300831 |
| 133 | PRKCB | 0.28966162 |
| 134 | GRK5 | 0.26841390 |
| 135 | SGK1 | 0.26612616 |
| 136 | PDGFRB | 0.26113887 |
| 137 | PIK3CA | 0.26039654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.39989113 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.79898881 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.43923961 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.72057962 |
| 5 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.59960366 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.53608991 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.47322225 |
| 8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.40565109 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.21478951 |
| 10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.11003422 |
| 11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.04127029 |
| 12 | GABAergic synapse_Homo sapiens_hsa04727 | 1.98322497 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.77444295 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.75214910 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.71783265 |
| 16 | Axon guidance_Homo sapiens_hsa04360 | 1.70287947 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.62804791 |
| 18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.54491939 |
| 19 | Nicotine addiction_Homo sapiens_hsa05033 | 1.47842462 |
| 20 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.47356383 |
| 21 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.40796044 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.38923161 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.37218079 |
| 24 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.36864446 |
| 25 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.36838713 |
| 26 | Circadian entrainment_Homo sapiens_hsa04713 | 1.34056075 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.27078353 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.26739794 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.26729834 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.22611561 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.22354082 |
| 32 | Protein export_Homo sapiens_hsa03060 | 1.22271793 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.21744854 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.18204587 |
| 35 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.17922002 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17882616 |
| 37 | Salivary secretion_Homo sapiens_hsa04970 | 1.17128911 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.15974888 |
| 39 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.15135870 |
| 40 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.13174033 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.11889232 |
| 42 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03057043 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.01271817 |
| 44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00969392 |
| 45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.00624626 |
| 46 | Glioma_Homo sapiens_hsa05214 | 0.99176446 |
| 47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.98438786 |
| 48 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.98248400 |
| 49 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.94731851 |
| 50 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.93512208 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.91024512 |
| 52 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.90206441 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89049520 |
| 54 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.87880383 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 0.87522472 |
| 56 | Tight junction_Homo sapiens_hsa04530 | 0.87209161 |
| 57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.86654414 |
| 58 | Prion diseases_Homo sapiens_hsa05020 | 0.86646111 |
| 59 | Taste transduction_Homo sapiens_hsa04742 | 0.85623186 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82912539 |
| 61 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82024872 |
| 62 | Endocytosis_Homo sapiens_hsa04144 | 0.81963484 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81850115 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80906386 |
| 65 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.80429284 |
| 66 | Renin secretion_Homo sapiens_hsa04924 | 0.77335328 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.76000649 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73929784 |
| 69 | Long-term potentiation_Homo sapiens_hsa04720 | 0.73751025 |
| 70 | Gap junction_Homo sapiens_hsa04540 | 0.73582090 |
| 71 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.72377025 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.70884177 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70363366 |
| 74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.70285346 |
| 75 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.68273445 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.68245550 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67054237 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66936700 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66004449 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65512750 |
| 81 | Mineral absorption_Homo sapiens_hsa04978 | 0.64506550 |
| 82 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64115468 |
| 83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62857864 |
| 84 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62695208 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61671376 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60499444 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.59853509 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59691210 |
| 89 | Insulin secretion_Homo sapiens_hsa04911 | 0.58095802 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57753359 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57207775 |
| 92 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.56732960 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55735518 |
| 94 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.55039628 |
| 95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55037707 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53375958 |
| 97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53327142 |
| 98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53010099 |
| 99 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52981261 |
| 100 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.52954354 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52616433 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.52410982 |
| 103 | Huntingtons disease_Homo sapiens_hsa05016 | 0.51020110 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50354531 |
| 105 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50308686 |
| 106 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50192045 |
| 107 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.49972449 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49557133 |
| 109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49268981 |
| 110 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.47739806 |
| 111 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44163449 |
| 112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43631014 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43561404 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.43423223 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43355256 |
| 116 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.41977939 |
| 117 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40359463 |
| 118 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38342008 |
| 119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37219351 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.37112127 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36095983 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34900935 |
| 123 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34683192 |
| 124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33537475 |
| 125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33454854 |
| 126 | Melanogenesis_Homo sapiens_hsa04916 | 0.33404877 |
| 127 | Alcoholism_Homo sapiens_hsa05034 | 0.32524213 |
| 128 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30833700 |
| 129 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30272590 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.23266338 |
| 131 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21744803 |
| 132 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.20100667 |
| 133 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.19461449 |
| 134 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.18115169 |

